Robert Tepper

Robert Tepper is on these Sector & Stage Rankings

Robert Tepper's Investments On Record (6)

Company	StageDateRound Size	Total Raised
Casma Therapeutics	Series CNov 2022$46M	$160M
Co-investors: Cary Pfeffer (Third Rock Ventures), Hiromichi Kimura (Astellas Venture Management), Millie Ray (The Column Group)
Constellation Pharmaceuticals	Series FApr 2018$100M Series EDec 2015$55M Series BJun 2011$15M Series BJun 2010$22M Series AAug 2009$17M Series AApr 2008$32M	$390M
Co-investors: Brian Gallagher (Abingworth), Tony Evnin (Venrock), David Goeddel (The Column Group)
Allena Pharmaceuticals	Series BDec 2014$25M Series ANov 2011$15M	$93M
Co-investors: Steve Kraus (Bessemer Venture Partners), James N. Topper (Frazier Healthcare Partners)
Kala Pharmaceuticals	Series BApr 2014$23M Series AFeb 2013$12M Private EquityMar 2012$7M	$110M
Co-investors: Kevin Bitterman (Atlas Venture), Karen Wagner (Ysios Capital)
Alcresta	Series BJul 2013$10M Series AApr 2012$10M	$69M
Co-investors: Steve Kraus (Bessemer Venture Partners), James N. Topper (Frazier Healthcare Partners)
Bluebird Bio	Series DJul 2012$60M Series CApr 2011$30M Series BMar 2010$35M	$130M
Co-investors: Geert-Jan Mulder (Forbion), Philip Reilly (Third Rock Ventures), Steven Gillis (ARCH Venture Partners)